16.09
BATS BZX Real-Time Price
As of 2:15pm ET
 -0.26 / -1.59%
Today’s Change
11.02
Today|||52-Week Range
17.21
+13.39%
Year-to-Date
New Strong Sell Stocks for February 21st
Feb 21 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close16.35
Today’s open16.31
Day’s range16.09 - 16.48
Volume17,581
Average volume (3 months)1,023,651
Market cap$1.8B
Data as of 2:15pm ET, 02/22/2018

Growth & Valuation

Earnings growth (last year)+120.75%
Earnings growth (this year)+70.29%
Earnings growth (next 5 years)+56.67%
Revenue growth (last year)+47.37%
P/E ratio18.2
Price/Sales7.83
Price/Book--

Competitors

 Today’s
change
Today’s
% change
PCRXPacira Pharmaceutica...-0.20-0.66%
EBSEmergent BioSolution...-0.15-0.30%
MYOKMyoKardia Inc+0.10+0.17%
LXRXLexicon Pharmaceutic...+0.71+8.70%
Data as of 2:12pm ET, 02/22/2018

Financials

Next reporting dateApril 26, 2018
EPS forecast (this quarter)$0.42
Annual revenue (last year)$217.2M
Annual profit (last year)$134.1M
Net profit margin61.76%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Michael W. Aguiar
Chief Financial Officer &
Senior Vice President
Eric d'Esparbes
Corporate headquarters
Brisbane, California

Forecasts